Matches in SemOpenAlex for { <https://semopenalex.org/work/W2209957364> ?p ?o ?g. }
- W2209957364 endingPage "80" @default.
- W2209957364 startingPage "173" @default.
- W2209957364 abstract "Targeting human epidermal growth factor receptor 2 (HER2) with trastuzumab in metastatic esophagogastric adenocarcinoma (EGA) improves survival. The impact of HER2 inhibition in combination with chemoradiotherapy (CRT) in early stage EGA is under investigation. This study analyzed the pattern of HER2 overexpression in matched-pair tumor samples of patients who underwent neoadjuvant CRT followed by surgery.All patients with EGA who underwent standard neoadjuvant CRT followed by esophagectomy at the University of Florida were included. Demographics, risk factors, tumor features, and outcome data were analyzed. Descriptive statistics, Chi-square exact test, uni- and multivariate analyses, and Kaplan Meier method were used. HER2 expression determined by immunohistochemical (IHC) was scored as negative (0, 1+), indeterminate (2+) or positive (3+).Among 49 sequential patients (41 M/8 F) with matched-pair tumor samples, 9/49 patients (18%) had pathologic complete response (pCR), 10/49 had near pCR or not enough tumor (NET) to examine in the post- treatment samples. Patients with initial HER2 negativity demonstrated conversion to HER2 positivity after neoadjuvant CRT (7/30 cases; 23%). Baseline HER2 overexpression was more common in lower stage/node negative patients (67% in stages I, IIA vs. 33% in stages IIB, III) and did not correlate with treatment response or survival.Although limited by a relatively small sample size, our study failed to demonstrate that baseline HER2 protein over-expression in EGA predicts response to standard CRT. However, our data suggested that HER2 was up regulated by CRT resulting in unreliable concordance between pre-treatment (pre-tx) and post-treatment (post-tx) samples. Pre-therapy HER2 expression may not reliably reflect the HER2 status of persistent or recurrent disease." @default.
- W2209957364 created "2016-06-24" @default.
- W2209957364 creator A5004700748 @default.
- W2209957364 creator A5009620190 @default.
- W2209957364 creator A5020154592 @default.
- W2209957364 creator A5029433870 @default.
- W2209957364 creator A5032632922 @default.
- W2209957364 creator A5040855705 @default.
- W2209957364 creator A5046488005 @default.
- W2209957364 creator A5054434791 @default.
- W2209957364 creator A5054877069 @default.
- W2209957364 creator A5059624097 @default.
- W2209957364 creator A5069022903 @default.
- W2209957364 creator A5069843364 @default.
- W2209957364 creator A5074319725 @default.
- W2209957364 creator A5083129512 @default.
- W2209957364 creator A5083228573 @default.
- W2209957364 date "2016-04-01" @default.
- W2209957364 modified "2023-09-26" @default.
- W2209957364 title "Discordant HER2 expression and response to neoadjuvant chemoradiotherapy in esophagogastric adenocarcinoma." @default.
- W2209957364 cites W1560977309 @default.
- W2209957364 cites W1807105923 @default.
- W2209957364 cites W1951105808 @default.
- W2209957364 cites W1964321121 @default.
- W2209957364 cites W1965537030 @default.
- W2209957364 cites W1969015681 @default.
- W2209957364 cites W1982992455 @default.
- W2209957364 cites W1987009448 @default.
- W2209957364 cites W1991256209 @default.
- W2209957364 cites W2000369564 @default.
- W2209957364 cites W2005399294 @default.
- W2209957364 cites W2014312052 @default.
- W2209957364 cites W2017176432 @default.
- W2209957364 cites W2028153418 @default.
- W2209957364 cites W2044433058 @default.
- W2209957364 cites W2057975185 @default.
- W2209957364 cites W2069755925 @default.
- W2209957364 cites W2075657881 @default.
- W2209957364 cites W2092862243 @default.
- W2209957364 cites W2100439220 @default.
- W2209957364 cites W2112750808 @default.
- W2209957364 cites W2122113038 @default.
- W2209957364 cites W2123206362 @default.
- W2209957364 cites W2127996441 @default.
- W2209957364 cites W2135990563 @default.
- W2209957364 cites W2138993970 @default.
- W2209957364 cites W2144958249 @default.
- W2209957364 cites W2151284103 @default.
- W2209957364 cites W2153845297 @default.
- W2209957364 cites W2154444715 @default.
- W2209957364 cites W2160308307 @default.
- W2209957364 cites W2166238279 @default.
- W2209957364 cites W4235795851 @default.
- W2209957364 doi "https://doi.org/10.3978/j.issn.2078-6891.2015.071" @default.
- W2209957364 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4783750" @default.
- W2209957364 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27034783" @default.
- W2209957364 hasPublicationYear "2016" @default.
- W2209957364 type Work @default.
- W2209957364 sameAs 2209957364 @default.
- W2209957364 citedByCount "3" @default.
- W2209957364 countsByYear W22099573642016 @default.
- W2209957364 countsByYear W22099573642018 @default.
- W2209957364 countsByYear W22099573642019 @default.
- W2209957364 crossrefType "journal-article" @default.
- W2209957364 hasAuthorship W2209957364A5004700748 @default.
- W2209957364 hasAuthorship W2209957364A5009620190 @default.
- W2209957364 hasAuthorship W2209957364A5020154592 @default.
- W2209957364 hasAuthorship W2209957364A5029433870 @default.
- W2209957364 hasAuthorship W2209957364A5032632922 @default.
- W2209957364 hasAuthorship W2209957364A5040855705 @default.
- W2209957364 hasAuthorship W2209957364A5046488005 @default.
- W2209957364 hasAuthorship W2209957364A5054434791 @default.
- W2209957364 hasAuthorship W2209957364A5054877069 @default.
- W2209957364 hasAuthorship W2209957364A5059624097 @default.
- W2209957364 hasAuthorship W2209957364A5069022903 @default.
- W2209957364 hasAuthorship W2209957364A5069843364 @default.
- W2209957364 hasAuthorship W2209957364A5074319725 @default.
- W2209957364 hasAuthorship W2209957364A5083129512 @default.
- W2209957364 hasAuthorship W2209957364A5083228573 @default.
- W2209957364 hasConcept C121608353 @default.
- W2209957364 hasConcept C126322002 @default.
- W2209957364 hasConcept C143998085 @default.
- W2209957364 hasConcept C146357865 @default.
- W2209957364 hasConcept C151730666 @default.
- W2209957364 hasConcept C160798450 @default.
- W2209957364 hasConcept C204232928 @default.
- W2209957364 hasConcept C2777297899 @default.
- W2209957364 hasConcept C2778292576 @default.
- W2209957364 hasConcept C2778424827 @default.
- W2209957364 hasConcept C2779742542 @default.
- W2209957364 hasConcept C2779786085 @default.
- W2209957364 hasConcept C2781182431 @default.
- W2209957364 hasConcept C38180746 @default.
- W2209957364 hasConcept C530470458 @default.
- W2209957364 hasConcept C71924100 @default.
- W2209957364 hasConcept C86803240 @default.
- W2209957364 hasConcept C90924648 @default.
- W2209957364 hasConceptScore W2209957364C121608353 @default.